Most Read Articles
Jairia Dela Cruz, 05 Oct 2020
Drinking more than two cups of coffee per day may just be the intervention that prevents hundreds of thousands of liver disease‐related deaths globally, a study reports.
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
Roshini Claire Anthony, 12 Oct 2020

Insulin icodec, an in-development basal insulin analogue administered once weekly, was as effective as once-daily insulin glargine in patients with type 2 diabetes (T2D) insufficiently controlled with metformin with or without a DPP-4* inhibitor, according to a phase II trial presented at EASD 2020.

Stephen Padilla, 2 days ago
Use of systemic corticosteroids does not reduce in-hospital mortality for patients with severe or critical coronavirus disease (COVID-19), which is in stark contrast to that observed in the RECOVERY clinical trial, according to a study in Wuhan, China.

Substance abuse ups risk of heart failure hospitalizations, readmissions

Stephen Padilla
23 Jan 2020
Substance abuse among the elderly is dangerous and require special attention to address the underlying problems.

Substance-abuse disorders (SADs) are not at all uncommon among patients with heart failure (HF), according to a study. Several SADs independently correlate with HF-related emergency department (ED) visits and hospitalizations.

“Evaluation of substance abuse history, particularly methamphetamine abuse, opioid use and abuse, and alcohol abuse, may identify patients at a greater risk for HF morbidity,” the researchers said. “Greater recognition and treatment of SADs may lead to improved outcomes among patients with HF.”

Medical records of HF patients treated at the University of California–San Diego from 2005 to 2016 were evaluated, and substance abuse was identified through diagnosis codes or urine drug screens. Incidence rate ratios (IRR) of substance abuse for ED visits or hospitalizations with a primary diagnosis of HF were estimated using Poisson regression, adjusted for age, sex, race, medical diagnoses and insurance status.

Over a follow-up of 49,712 person-years, a total of 11,269 HF patients and 15,909 hospital encounters for HF were identified. Of the patients, 15.2 percent were diagnosed with substance abuse. [Am J Med 2020;133:207-213.e1]

SADs such as methamphetamine abuse (prevalence, 5.2 percent; IRR, 1.96, 95 percent confidence interval [CI], 1.85–2.07), opioid use and abuse (prevalence, 8.2 percent; IRR, 1.54, 95 percent CI, 1.47–1.61), and alcohol abuse (prevalence, 4.5 percent; IRR, 1.51, 95 percent CI, 1.42–1.60) correlated with a higher rate of hospital encounters for HF.

These associations were comparable to other comorbidity diagnoses such as atrial fibrillation (prevalence, 37 percent; IRR, 1.78, 95 percent CI, 1.73–1.84), ischaemic heart disease (prevalence, 24 percent; IRR, 1.67, 95 percent CI, 1.62–1.73) and chronic kidney disease (prevalence, 26 percent; IRR, 1.57, 95 percent CI, 1.51–1.62).

The most commonly used substance was opioids, followed by methamphetamine, alcohol, marijuana and cocaine. Annual incidence of opioid use decreased over the study period from 9.6 percent to 4.1 percent, mirroring that in the general population. In contrast, methamphetamine abuse increased between 2006 and 2016 from 1.8 percent to 6.4 percent. [J Pain 2016;17:101-110]

Many abused substances have toxic effects, the researchers said. Cocaine, for instance, can cause several adverse cardiovascular effects, such as hypertension, myocardial ischaemia, arrhythmia, aortic dissection and stroke. [J Am Coll Cardiol 2017;70:101-113; Med Res Rev 2018;38:1332-1403]

Alcohol may also induce hypertension, as well as atrial fibrillation and alcoholic cardiomyopathy. Methamphetamine use is also associated with cardiovascular complications, including HF and pulmonary hypertension. [Med Res Rev 2018;38:1332-1403; Heart Lung Circ 2016;25:325-332; Circ Cardiol 2013;36:737-742]

However, despite the robust correlation between substance abuse and HF-related hospital encounters, no association was found between substance abuse and mortality, according to the researchers.

“It is likely that given relative youth of the patients with a substance abuse history, the baseline level of risk for mortality was lower among patients with [vs without] substance abuse,” they added.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Psychiatry - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Jairia Dela Cruz, 05 Oct 2020
Drinking more than two cups of coffee per day may just be the intervention that prevents hundreds of thousands of liver disease‐related deaths globally, a study reports.
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
Roshini Claire Anthony, 12 Oct 2020

Insulin icodec, an in-development basal insulin analogue administered once weekly, was as effective as once-daily insulin glargine in patients with type 2 diabetes (T2D) insufficiently controlled with metformin with or without a DPP-4* inhibitor, according to a phase II trial presented at EASD 2020.

Stephen Padilla, 2 days ago
Use of systemic corticosteroids does not reduce in-hospital mortality for patients with severe or critical coronavirus disease (COVID-19), which is in stark contrast to that observed in the RECOVERY clinical trial, according to a study in Wuhan, China.